Raj Kavitha P, Taylor Thomas H, Wray Charlie, Stamos Michael J, Zell Jason A
Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Dept. of Medicine, School of Medicine, University of California Irvine, Irvine CA, USA.
J Carcinog. 2011 Mar 17;10:6. doi: 10.4103/1477-3163.78114.
Patients with history of colorectal cancer (CRC) are at increased risk for developing a second primary colorectal cancer (SPCRC) as compared to the general population. However, the degree of risk is uncertain. Here, we attempt to quantify the risk, using data from the large population-based California Cancer Registry (CCR).
We analyzed the CCR data for cases with surgically-treated colon and rectal cancer diagnosed during the period 1990-2005 and followed through up to January 2008. We excluded those patients diagnosed with metastatic disease and those in whom SPCRC was diagnosed within 6 months of the diagnosis of the primary CRC. Standardized incidence ratios (SIR) with 95% confidence intervals (CI) were calculated to evaluate risk as compared to the underlying population after taking into account age, sex, ethnicity, and time at risk.
The study cohort consisted of 69809 cases with colon cancer and 34448 with rectal cancer. Among these patients there were 1443 cases of SPCRCs. The SIR for developing SPCRC was higher in colon cancer survivors (SIR=1.4; 95% CI: 1.3 to 1.5) as compared to the underlying population. The incidence of SPCRC was also higher in females (SIR=1.5; 95% CI: 1.3 to 1.6) and Hispanics (SIR=2.0; 95% CI: 1.7 to 2.4) with primary colon cancer. The SIR for developing an SPCRC was higher only among those whose initial tumor was located in the descending colon (SIR=1.6; 95% CI: 1.3 to 2.0) and proximal colon (SIR=1.4; 95% CI: 1.3 to 1.6).
Our results confirm that CRC patients, especially females and Hispanics, are at a higher risk of developing SPCRC than the general population. Differential SPCRC risk by colorectal tumor subsite is dependent on gender and ethnicity, underscoring the heterogeneous nature of CRC.
与普通人群相比,有结直肠癌(CRC)病史的患者发生第二原发性结直肠癌(SPCRC)的风险增加。然而,风险程度尚不确定。在此,我们尝试利用基于人群的大型加利福尼亚癌症登记处(CCR)的数据来量化该风险。
我们分析了CCR数据,这些数据来自于1990年至2005年期间诊断为结肠癌和直肠癌且接受手术治疗并随访至2008年1月的病例。我们排除了那些诊断为转移性疾病的患者以及那些在原发性CRC诊断后6个月内被诊断为SPCRC的患者。在考虑年龄、性别、种族和风险时间后,计算标准化发病率比(SIR)及其95%置信区间(CI),以评估与基础人群相比的风险。
研究队列包括69809例结肠癌病例和34448例直肠癌病例。在这些患者中,有1443例SPCRC病例。与基础人群相比,结肠癌幸存者发生SPCRC的SIR更高(SIR = 1.4;95% CI:1.3至1.5)。原发性结肠癌女性(SIR = 1.5;95% CI:1.3至1.6)和西班牙裔(SIR = 2.0;95% CI:1.7至2.4)中SPCRC的发病率也更高。仅在初始肿瘤位于降结肠(SIR = 1.6;95% CI:1.3至2.0)和近端结肠(SIR = 1.4;95% CI:1.3至1.6)的患者中,发生SPCRC的SIR更高。
我们的结果证实,CRC患者,尤其是女性和西班牙裔,发生SPCRC的风险高于普通人群。结直肠肿瘤亚部位的SPCRC风险差异取决于性别和种族,这突出了CRC的异质性。